HIGH CONCENTRATION, NO IRRITATION
DermShield™ is a revolutionary skincare technology that enables the formulation of active ingredients at breakthrough high concentration levels without causing skin irritation and other side effects.
The Challenge With High- Strength Therapeutic Skincare
The Noon Aesthetics™ Solution: Introducing DermShield™
DermShield™ technology enables the use of high concentration levels of active ingredients without the risk of side effects on all skin types, all year round.
How DermShield™ Works
DermShield™ temporarily inhibits the chemical-sensitive receptors in the skin (called Type C Nociceptors) which are responsible for triggering neurogenic inflammation, redness, and irritation of the skin. By inhibiting C Nociceptors innervations in the skin, DermShield™ dramatically reduces the sensation of irritation and stinging, redness, and other symptoms of neurogenic inflammation. This, in turn, allows NOON™ to significantly increase the concentration of therapeutic active ingredients without triggering adverse side effects such as excessive irritation and redness.
The DermShield™’s Mechanism of Action:
- Temporary inhibition of type C Nociceptors in the skin.
- Reduced alarm signal transmissions to the brain.
- Decreased development of neurogenic inflammation, irritation, and redness.
- Much more pleasant treatment experience, no side effects, and more dramatic results due to higher concentration of active ingredients.
DermShield™ Clinical Study
The Efficacy and Safety of a Novel Protective Complex Combined with 50% Glycolic Acid Peel: A Double- Blinded, Split Face, Controlled Study Ofir Artzi MD, Lee Heyman MD, Rafael L. Carasso MD, Joseph N. Mehrabi MSc, JDD, December 2021
Description #5: A recent clinical study (Dec 2021) published in the Journal of Drags in Dermatology (JDD) demonstrated the efficacy and safety of the DermShield™ technology in a double-blinded, split-face, controlled settings. The study demonstrated a 95% reduction in neurogenic inflammation reaction, redness, and irritation, as well as significantly shorter recovery time, when DermShield™ technology was used. The study concluded that DermShield™ technology is a “highly effective, safe modality in the reduction of erythema, pain, and itching after 50% glycolic acid peeling, and it provides an advantage in the post-healing treatment period”